Key risk factors include delayed childbearing and declining fertility rates, limited access to regular gynecological care and ...

Polycystic Ovary Syndrome is rising among Indian women, especially in urban areas. This article explores its symptoms, ...

A transvaginal ultrasound, although intrusive, is preferred for accuracy. This involves the insertion of a wand-like instrument into the vagina, which can be uncomfortable, especially for those ...

On the basis of differences in histology and clinical outcomes, endometrial cancers have long been divided into two types. 1–4 Type I tumors comprise the large majority of endometrial cancers, are ...

Genmab A/S. Media Release COPENHAGEN, Denmark; June 2, 2025. New data showed that rinatabart sesutecan (Rina-S ®) 100 mg/m 2 led to a confirmed objective response rate (ORR) of 50.0 percent ...

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S ®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL ...

The NHS has agreed a pair of commercial deals with Merck & Co/MSD and Eisai that will allow hundreds of women with advanced endometrial cancer to get access to life-extending combination therapy ...

Endometrial cancer is the second most common gynecologic cancer and the sixth most common cancer among women globally. In 2022, ~420,000 cases were diagnosed, which led to ~97,000 deaths worldwide.

GSK views the endometrial cancer indication as a catalyst to grow annual sales of Jemperli above the £1 billion ($1.27 billion) threshold, its target for the drug, which was acquired as part of ...

Teddi’s new romance comes less than three months after the Bravolebrity opened up about how difficult her dating life has been amid her cancer battle. “I had gone on four or five dates with ...